Regulatory Guidelines

Pharma stability studies evaluate the effects of environmental factors such as temperature, humidity, and light on pharmaceutical products. These studies ensure that drugs maintain their intended safety, quality, and efficacy throughout their lifecycle. By following standardized ICH stability guidelines, manufacturers can confidently determine shelf life, storage conditions, and packaging requirements for their products.
Click to read the full article.

Pharmaceutical stability testing ensures that a drug maintains its quality, safety, and efficacy throughout its shelf life. The International Council for Harmonisation (ICH) guideline Q1A(R2) is the cornerstone for stability studies, offering detailed protocols for evaluating how environmental factors such as temperature, humidity, and light affect a drug product over time. This guideline is globally accepted, enabling pharmaceutical companies to streamline their stability programs and meet regulatory requirements across markets.
Click to read the full article.

In the pharmaceutical industry, ensuring that drug products maintain their intended quality, safety, and efficacy over time is paramount. Stability testing plays a crucial role in this process, and the U.S. Food and Drug Administration (FDA) provides comprehensive guidelines to standardize these studies. These FDA stability guidelines influence every stage of pharmaceutical product development, from formulation to regulatory approval, shaping the global drug market. This article explores how FDA stability guidelines impact the development of pharmaceuticals, focusing on key requirements, processes, and their significance.
Click to read the full article.

Stability testing is a fundamental aspect of pharmaceutical development, ensuring that drugs remain safe, effective, and of high quality throughout their shelf life. In Europe, the European Medicines Agency (EMA) has established stringent stability guidelines to regulate drug approvals and market entry. These guidelines align with international standards, such as the ICH stability guidelines, while addressing specific European market requirements. This article explores the EMA stability guidelines, their application in product development, and their role in navigating the complex European regulatory landscape.
Click to read the full article.

Stability testing is a vital aspect of pharmaceutical product development, ensuring that medicines remain effective, safe, and of high quality throughout their shelf life. In Australia, the Therapeutic Goods Administration (TGA) oversees the regulation of stability testing, aligning with global standards like the ICH stability guidelines while addressing unique regional requirements. This article provides an in-depth overview of the TGA guidelines for stability testing in pharmaceuticals, offering insights into their significance, key requirements, and impact on drug development for the Australian market.
Click to read the full article.